Abecma, developed in partnership with Bristol-Myers Squibb, for treating patients with newly diagnosed multiple myeloma.

Discover Bristol-Myers Squibb's groundbreaking patent for personalized SLE treatment, utilizing IKZF3 gene expression to optimize dosage for better patient outcomes.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Catherine Owen Adams has succeeded Steve Davis as Chief Executive Officer (CEO) and joined the Acadia Board of Directors.

A pharmaceutical giant that made a splashy, incentive-backed entrance to Tampa over 10 years ago plans to slash its office ...

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) shares are trading lower by 4.11% to $15.62 during Tuesday’s session after the ...

Results have been positive, with SHR-1701 demonstrating improvements in overall survival, but taking market share will be a ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Bristol-Myers Squibb Co. has announced it will acquire Amylin Pharmaceuticals for approximately US $5.3 billion in cash. Following the completion of this acquisition, Bristol-Myers Squibb will ...

TENS of thousands of Brits are estimated to be unknowingly living with the silent heart condition that nearly killed ...

BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) today and set a price target ...

Nevada U.S. Senator Jacky Rosen, Colleagues File Amicus Brief Urging Court to Uphold Medicare’s Ability to Negotiate Lower ...

The Deerfield life sciences agency has bolstered its comms and marketing team with two new senior hires. | The Deerfield life ...